Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12441 | 905 | 28.0 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
498 | 3 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//WILMS TUMOR | 22561 |
1899 | 2 | NEUROBLASTOMA//ALVEOLAR SOFT PART SARCOMA//MYCN | 5933 |
12441 | 1 | I 131 MIBG//METAIODOBENZYLGUANIDINE//MIBG | 905 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | I 131 MIBG | authKW | 1218800 | 6% | 71% | 51 |
2 | METAIODOBENZYLGUANIDINE | authKW | 750981 | 7% | 35% | 64 |
3 | MIBG | authKW | 531345 | 7% | 27% | 59 |
4 | I 131 METAIODOBENZYLGUANIDINE | authKW | 330047 | 2% | 65% | 15 |
5 | NEUROBLASTOMA | authKW | 303576 | 24% | 4% | 219 |
6 | 3 IODOBENZYLGUANIDINE | authKW | 236161 | 2% | 50% | 14 |
7 | I 131 MIBG THERAPY | authKW | 196297 | 1% | 73% | 8 |
8 | MIBG SCAN | authKW | 165318 | 1% | 70% | 7 |
9 | 131 I METAIODOBENZYLGUANIDINE | authKW | 107964 | 0% | 80% | 4 |
10 | MIBG THERAPY | authKW | 105431 | 1% | 63% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 16832 | 52% | 0% | 475 |
2 | Oncology | 2216 | 27% | 0% | 242 |
3 | Pediatrics | 1234 | 13% | 0% | 122 |
4 | Hematology | 97 | 4% | 0% | 36 |
5 | Nuclear Science & Technology | 46 | 3% | 0% | 26 |
6 | Medicine, General & Internal | 34 | 5% | 0% | 42 |
7 | MEDICINE, MISCELLANEOUS | 19 | 0% | 0% | 1 |
8 | Chemistry, Inorganic & Nuclear | 14 | 3% | 0% | 23 |
9 | Chemistry, Medicinal | 9 | 2% | 0% | 16 |
10 | Biochemical Research Methods | 8 | 2% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TARGETED THER Y GRP | 103319 | 1% | 44% | 7 |
2 | W GLASGOW HOSP UNIV TRUST | 101218 | 0% | 100% | 3 |
3 | GLASGOW CANC STUDIES | 67478 | 0% | 100% | 2 |
4 | SEMONOV | 67478 | 0% | 100% | 2 |
5 | CANC UNITED KINGDOM BEATSON S | 44984 | 0% | 67% | 2 |
6 | ABRAMSON PEDIAT 902A ONCOL | 33739 | 0% | 100% | 1 |
7 | ABT SAUERSTOFFUBERDRUCK MED | 33739 | 0% | 100% | 1 |
8 | ANTONI VAN LEEUWENHOEKHUIS NUCL MED | 33739 | 0% | 100% | 1 |
9 | BIOL VIA ORAZIO RAIMONDO 1 | 33739 | 0% | 100% | 1 |
10 | CANC B1208 PEDIAT HEMATOL ONCOL | 33739 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE | 23154 | 1% | 5% | 13 |
2 | MEDICAL AND PEDIATRIC ONCOLOGY | 21566 | 4% | 2% | 40 |
3 | JOURNAL OF NUCLEAR MEDICINE | 18660 | 8% | 1% | 75 |
4 | CLINICAL NUCLEAR MEDICINE | 15930 | 6% | 1% | 56 |
5 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 12739 | 4% | 1% | 35 |
6 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 12219 | 2% | 3% | 14 |
7 | NUKLEARMEDIZINER | 8195 | 1% | 4% | 6 |
8 | SEMINARS IN NUCLEAR MEDICINE | 7798 | 2% | 1% | 17 |
9 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 7096 | 3% | 1% | 26 |
10 | NUCLEAR MEDICINE COMMUNICATIONS | 6340 | 3% | 1% | 28 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | I 131 MIBG | 1218800 | 6% | 71% | 51 | Search I+131+MIBG | Search I+131+MIBG |
2 | METAIODOBENZYLGUANIDINE | 750981 | 7% | 35% | 64 | Search METAIODOBENZYLGUANIDINE | Search METAIODOBENZYLGUANIDINE |
3 | MIBG | 531345 | 7% | 27% | 59 | Search MIBG | Search MIBG |
4 | I 131 METAIODOBENZYLGUANIDINE | 330047 | 2% | 65% | 15 | Search I+131+METAIODOBENZYLGUANIDINE | Search I+131+METAIODOBENZYLGUANIDINE |
5 | NEUROBLASTOMA | 303576 | 24% | 4% | 219 | Search NEUROBLASTOMA | Search NEUROBLASTOMA |
6 | 3 IODOBENZYLGUANIDINE | 236161 | 2% | 50% | 14 | Search 3+IODOBENZYLGUANIDINE | Search 3+IODOBENZYLGUANIDINE |
7 | I 131 MIBG THERAPY | 196297 | 1% | 73% | 8 | Search I+131+MIBG+THERAPY | Search I+131+MIBG+THERAPY |
8 | MIBG SCAN | 165318 | 1% | 70% | 7 | Search MIBG+SCAN | Search MIBG+SCAN |
9 | 131 I METAIODOBENZYLGUANIDINE | 107964 | 0% | 80% | 4 | Search 131+I+METAIODOBENZYLGUANIDINE | Search 131+I+METAIODOBENZYLGUANIDINE |
10 | MIBG THERAPY | 105431 | 1% | 63% | 5 | Search MIBG+THERAPY | Search MIBG+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PARISI, MT , ESLAMY, H , PARK, JR , SHULKIN, BL , YANIK, GA , (2016) I-131-METAIODOBENZYLGUANIDINE THERANOSTICS IN NEUROBLASTOMA: HISTORICAL PERSPECTIVES; PRACTICAL APPLICATIONS.SEMINARS IN NUCLEAR MEDICINE. VOL. 46. ISSUE 3. P. 184 -202 | 81 | 84% | 2 |
2 | DUBOIS, SG , MATTHAY, KK , (2008) RADIOLABELED METAIODOBENZYLGUANIDINE FOR THE TREATMENT OF NEUROBLASTOMA.NUCLEAR MEDICINE AND BIOLOGY. VOL. 35. ISSUE . P. S35-S48 | 78 | 85% | 29 |
3 | STREBY, KA , SHAH, N , RANALLI, MA , KUNKLER, A , CRIPE, TP , (2015) NOTHING BUT NET: A REVIEW OF NOREPINEPHRINE TRANSPORTER EXPRESSION AND EFFICACY OF I-131-MIBG THERAPY.PEDIATRIC BLOOD & CANCER. VOL. 62. ISSUE 1. P. 5 -11 | 64 | 74% | 5 |
4 | DUBOIS, SG , MATTHAY, KK , (2013) I-131-METAIODOBENZYLGUANIDINE THERAPY IN CHILDREN WITH ADVANCED NEUROBLASTOMA.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 57. ISSUE 1. P. 53-65 | 65 | 74% | 7 |
5 | CARRASQUILLO, JA , PANDIT-TASKAR, N , CHEN, CC , (2012) RADIONUCLIDE THERAPY OF ADRENAL TUMORS.JOURNAL OF SURGICAL ONCOLOGY. VOL. 106. ISSUE 5. P. 632 -642 | 72 | 67% | 9 |
6 | BLEEKER, G , TYTGAT, GAM , ADAM, JA , CARONA, HN , KREMER, LCM , HOOFT, L , VAN DALEN, EC , (2015) 123I-MIBG SCINTIGRAPHY AND 18F-FDG-PET IMAGING FOR DIAGNOSING NEUROBLASTOMA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 83 | 54% | 0 |
7 | CHARRON, M , (2013) CONTEMPORARY APPROACH TO DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 57. ISSUE 1. P. 40-52 | 57 | 76% | 5 |
8 | VOO, S , BUCERIUS, J , MOTTAGHY, FM , (2011) I-131-MIBG THERAPIES.METHODS. VOL. 55. ISSUE 3. P. 238-245 | 61 | 74% | 7 |
9 | TAGGART, D , DUBOIS, S , MATTHAY, KK , (2008) RADIOLABELED METAIODOBENZYLGUANIDINE FOR IMAGING AND THERAPY OF NEUROBLASTOMA.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 52. ISSUE 4. P. 403 -418 | 65 | 71% | 33 |
10 | SISSON, JC , YANIK, GA , (2012) THERANOSTICS: EVOLUTION OF THE RADIOPHARMACEUTICAL META-IODOBENZYLGUANIDINE IN ENDOCRINE TUMORS.SEMINARS IN NUCLEAR MEDICINE. VOL. 42. ISSUE 3. P. 171 -184 | 75 | 56% | 15 |
Classes with closest relation at Level 1 |